Aktiesnakken — Februar 2011
-
Vi siger farvel til Julian CFO, som har været der igennem 24 Q
-
- 2010 dividend up 7% to 65p; priority is to deliver further growth
-
- 2010 sales -1%; underlying sales growth 4.5%*
-
- Long-term share buy-back programme initiated (£1-2 billion expected in 2011)
-
Han taler lidt om de store omvæltninger i omsætningen
-
De har nogle helt hen i skoven udgifter til retssager
-
Pharma har det tough p.t.
-
hvilke kommer ud først af krisen
-
han kører historien igen om pharmas tab af "hvide pille salg"
-
samt mega historien om Vest - Øst
-
Jyske netbank er midlertidig ude af drift, bare så man kan se at dem skal man ikke skifte til !!
-
US pharma vender et hjørne
-
det går hurtigt
-
hvem ejer kunderne, hvem tager beslutningen
-
US steg 3% selv efter healtcare
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind